Conformis, Inc.
- Jurisdiction
United States - ISIN
US20717E1010 (CFMS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
2
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. Read full profile
Stock price
Fundamentals
- Net revenue
€48.85M - Gross margin
33.2% - EBIT
-€34.69M - EBIT margin
-71.0% - Net income
-€35.53M - Net margin
-72.7%
Statement period: - (published )
Dividends
No dividend payouts
Earnings Calls
Latest earnings call: May 8, 2023